https://www.selleckchem.com/products/ski-ii.html
upport was safe or effective for the treatment of transient tachypnea of the newborn. Copyright © 2020 The Cochrane Collaboration. Published by John Wiley Sons, Ltd.This analysis developed a population pharmacokinetic (PK) model for odanacatib, characterized demographic and concomitant medication covariates effect, and provided odanacatib exposure estimates for subjects in phase 2/3 studies. Data from multiple phase 1 (P005, P025, and P014), phase 2b (P004 and P022), and phase 3 (Long-Term Odanacatib Fracture Trial; P018) studies w
Curtir
Comentario
Compartilhar
